Babcock varsity begins research on remedy for pandemic
Anambra State has recorded two passings at Ufuma and Onitsha and 10 affirmed cases emerging from the COVID-19 pandemic, in the midst of refusal by the state government, portraying the cases as questionable.
It discovered that one of the cases is a 66-year elderly person who was among the 10 affirmed cases so far recorded in the state, while the other case was said to have contracted it from the accomplice who passed on undetected until test affirmed the expired’ status.
Nonetheless, Governor Willie Obiano, in a statewide communicate said the state has just one case out of the 10 cases affirmed by the Nigeria Center for Disease Control (NCDC), including that the casualty didn’t answer to the well-being place on schedule.
He said clarify that the main COVID-19 demise recorded so far in the state was a 66-year elderly person who didn’t report his evil well-being on schedule, including, “The case was accounted for late to the clinic and when his outcome returned constructive, after 24 hours, he had passed on.”
Then, Vice-Chancellor of Babcock University, Professor Ademola Tayo, has said the foundation has amassed a group of scientists to discover treatment for the coronavirus pandemic.
The News Agency of Nigeria (NAN) reports that Professor Tayo uncovered this in an announcement gave by the organization’s Director of Marketing and Communication, Joshua Suleiman.
As per the bad habit chancellor, the group has submitted examine recommendations on COVID-19 to pertinent government foundations for sponsorship and is hanging tight for endorsement.
“Babcock University has put together a team of researchers to find a cure to the coronavirus pandemic. Our faculties in the departments of Public Health and Agriculture, who are currently researching on COVID-19, have submitted research proposals on it to the Nigerian Institute of Animal Science (NIAS) for sponsorship.
“We also do hope that private universities will be eligible for the Federal Government’s funding for research on COVID-19 vaccine so we can benefit from it,” he said.